Global Biotechnology Market Size to Reach USD 5.01 Trillion in 2032 | Emergen Research

Innovations and advent of novel technologies, increasing medical applications of fermentation technology and increasing Research & Development (R&D) activities in tissue culture and cell engineering are key factors driving Biotechnology market revenue growth

Vancouver, Dec. 19, 2023 (GLOBE NEWSWIRE) — The global biotechnology market, valued at USD 5.01 Trillion in 2032, is set to experience a rapid revenue compound annual growth rate (CAGR) of 13.8% during the forecast period. Key drivers include groundbreaking innovations, the emergence of novel technologies, and a surge in Research & Development (R&D) activities, particularly in tissue culture and cell engineering.

Biotechnology, spanning fields such as biochemistry, genetics, and molecular biology, utilizes biological systems to create products. Notably, innovative technologies like Three Dimensional (3D) bioprinting are making waves in medicine, offering the potential to create human body parts and revolutionize drug development using patients’ own cells.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) https://www.emergenresearch.com/request-sample/2568

Genomic analytic techniques, such as microbial identification and detection of genetic changes, are in high demand for diagnosing major infectious diseases. However, the market faces challenges such as the risks associated with genetic data, the high cost of biotechnology reagents, obstacles in Next-Generation Sequencing (NGS) implementation, and ethical and legal limitations.

In 2022, the fermentation segment claimed the largest revenue share in the global biotechnology market. This dominance is attributed to the increasing use of fermentation technology in producing medical products like ethanol, antibiotics, probiotics, and compounds such as citric acid. Advances in bioreactor technology, including simplified and vortex bioreactors, have further propelled fermentation advancements.

The nanotechnology segment is expected to witness rapid revenue growth, driven by its expanding applications in biomedical fields, including drug delivery, gene therapy, molecular imaging, biomarkers, and biosensors. Ongoing advancements in nanomedicine for various medical disciplines contribute to the segment’s growth.

The health segment is poised to capture a significant revenue share in the global biotechnology market during the forecast period. Factors such as the focus on regenerative medicines, availability of agri-biotech and bio-services, and improvements in healthcare infrastructure drive this dominance.

Bioinformatics is anticipated to register a moderately fast revenue growth rate. The increasing adoption of tools for analyzing complex sequencing data fuels growth in this segment, evident in strategic mergers and acquisitions by key players to strengthen their capabilities.

In 2022, the North America market held the largest revenue share in the global biotechnology market, propelled by a rising demand for biotechnology, integration of new technologies, and a growing need for organic medicines and drugs. The U.S. market, in particular, led with significant contributions from major players and increased R&D activities.

The Europe market is expected to register the fastest revenue growth rate, driven by collaborations, product launches, business expansion, and strategic developments. Germany emerges as a major contributor, exemplified by Bayer AG’s opening of a USD 140 million U.S. cancer research and innovation center in June 2022.

The Asia Pacific market is anticipated to account for a considerably large revenue share, fueled by the increasing prevalence of chronic diseases and a surge in product launches. Notably, Parse Biosciences collaborates with India-based Spinco Biotech to expand its footprint in the Asian market.

In conclusion, the global biotechnology market continues its upward trajectory, fueled by innovations, collaborations, and a surge in R&D activities. As technology evolves, especially in fermentation and nanotechnology, and with key players making strategic moves, the industry is poised for robust growth

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2568

Scope of Research

Major Companies and Competitive Landscape

The global biotechnology market is fragmented with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective biotechnology products in the market. Some major players included in the global biotechnology market report are:

• AstraZeneca
• Gilead Sciences, Inc.
• Novo Nordisk A/S
• Abbott Laboratories
• Amgen Inc.
• Thermo Fisher Scientific Inc.
• Merck KgaA
• Johnson & Johnson Services, Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Moderna Inc.
• Bristol-Myers Squibb
• Becton, Dickinson and Company
• Danaher Corporation
• Medtronic plc
• Biogen Inc.
• Bayer AG
• Eli Lily and Company
• AbbVie Inc.

Strategic Development

• In November 2022, AstraZeneca announced to acquire Neogene Therapeutics Inc. into its portfolio, united in its mission to introduce cutting-edge cell therapies for patients battling solid tumors. With a shared commitment to advancing biotechnological approaches, the inclusion of TCR-Ts (cell therapy) from Neogene brings the potential to identify intracellular targets, including cancer-specific mutations, thus opening new possibilities for targeting previously inaccessible markers through cell therapies.
• In August 2022, Gilead Sciences, Inc. acquired MiroBio, gaining access to their exclusive biotechnology discovery platform and comprehensive portfolio of immune inhibitory receptor agonists. The integration of MiroBio’s proficiency in checkpoint receptor signaling and proprietary biotechnology methods for generating exceptional agonist antibodies synergizes seamlessly with Gilead’s drug development and therapeutic area knowledge

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2568

For the purpose of this report, Emergen Research has segmented the global biotechnology market on the basis of technology, applications, and region:

• Technology Outlook (Revenue, USD Trillion; 2019-2032)
  • Tissue Engineering and Regeneration
  • Nanobiotechnology
  • DNA Sequencing
  • Cell-based Assays
  • Fermentation
  • PCR Technology
  • Chromatography
  • Others
• Application Outlook (Revenue, USD Trillion; 2019-2032)
  • Health
  • Food & Agriculture
  • Natural Resources & Environment
  • Industrial Processing
  • Bioinformatics
  • Others
• Regional Outlook (Revenue, USD Trillion; 2019–2032)
  • North America
    1. U.S.
    2. Canada
  • Europe
    1. Germany
    2. France
    3. UK
    4. Italy
    5. Spain
    6. Benelux
    7. Russia
    8. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. India
    5. ASEAN Countries
    6. Oceania
    7. Rest of APAC
  • Latin America
    1. Brazil
    2. Mexico
    3. Rest of LATAM
  • Middle East & Africa
    1. GCC Countries
    2. Israel
    3. Turkey
    4. South Africa
    5. Rest of Middle East & Africa

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/biotechnology-market

Curated Reports You Shouldn’t Miss: Dive In Now!

Edge Analytics Market By Component (Services, Solution), By Type (Prescriptive Analytics, Descriptive Analytics, Diagnostic Analytics, Predictive Analytics), By Deployment (On-Cloud, On-Premises), By End-Use (Manufacturing, Energy and Power, and others), By Region Forecasts to 2027.

Prenatal Testing and Newborn Screening Market By Diagnostic Type (Invasive and Non-invasive), By Technology (Screening and Diagnostic Technology), By End-use, and By Region Forecast to 2030.

Blockchain in Energy Market By Type (Public, Private), By Component (Services, Platform), By Application (Peer-To-Peer Transaction, Grid Transactions, Energy Financing, Electric Vehicle, Sustainability Attribution, Others), By End-Use (Oil & Gas, Power), By Region Forecasts to 2027.

Hematologic Malignancies Testing Market By Product (Services, Kits), By Technology (Polymerase Chain Reaction, Immunohistochemistry, Next-generation sequencing, Fluorescence in situ hybridization), By Disease, By End-Use, By Region Forecasts to 2027.

Occlusion Devices Market By Product Type (Occlusion Removal Devices, Embolization Devices, and Support Devices), By Application (Neurology, Cardiology, Urology, Peripheral Vascular Diseases, Oncology, Others), By End-Users (Hospitals, Diagnostics Centers, Ambulatory Surgical Centers, Research Institutes, and Others), Forecasts to 2027.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights